Aberrant DNA methylation and miRNAs in coronary artery diseases and stroke: a systematic review

Insights

Epigenetic factors like DNA methylation and microRNA (miRNA) expression significantly influence cardiovascular diseases (CVDs), including coronary artery disease (CAD) and stroke. Understanding these epigenetic mechanisms is crucial for disease predisposition and treatment.

Area of Science:

  • Cardiovascular Epigenetics
  • Molecular Biology
  • Genomics

Background:

  • Coronary artery disease (CAD) and ischemic stroke are leading causes of cardiovascular diseases (CVDs).
  • Epigenetic factors, particularly DNA methylation and microRNA (miRNA) expression, play a critical role in CVD development and progression.
  • Understanding these epigenetic modifications is essential for identifying new therapeutic targets.

Purpose of the Study:

  • To systematically review and synthesize current knowledge on the roles of DNA methylation and miRNAs in CAD and stroke.
  • To highlight key epigenetic alterations and their associated biological pathways in these cardiovascular conditions.

Main Methods:

  • Comprehensive literature search of PubMed, Science Direct, and Scopus databases.
  • Systematic review of studies investigating DNA methylation and miRNA in CAD and stroke.
  • Network analysis using ClueGO software and miRTargetLink database for pathway and gene interaction analysis.

Main Results:

  • 32 studies on DNA methylation in CAD and stroke revealed alterations in global, genome-wide, and candidate loci methylation.
  • Network analysis indicated that DNA methylation influences nitric oxide biosynthesis, homocysteine metabolism, and lipid storage.
  • 83 studies identified 155 miRNAs associated with CAD and stroke, with specific miRNAs like mir-223 linked to cerebral infarction; common miRNAs targeted SP3 and SP1 genes.

Conclusions:

  • Abnormal DNA methylation and miRNA expression are significantly implicated in the etiology and progression of CAD and stroke.
  • Epigenetic dysregulation represents a key area for future research and potential therapeutic interventions in cardiovascular diseases.
  • Further investigation into specific epigenetic mechanisms and their targets can lead to improved diagnostics and treatments for CAD and stroke.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
805
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
309
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
543
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K